Journal of Metabolic and Bariatric Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5956   pISSN 2287-2930

Table. 4.

Table. 4.

Summary of key results from the studies included in literature review and meta-analysis

Author No. of patients Gender Age (years) Duration of T1DM (years) Follow-up period (month) BMI before/after surgery (kg/m2) BMI loss (kg/m2) %EBMIL (%) HbA1c before/after surgery (%) Change in HbA1c Insulin dosage before/after surgery (units) Change in dosage Other improved comorbidities Complications
Feilitzsch et al. [15] 2011 1 F 37 12 6 46/37 11 42.9 10/NA NA 700/60 -690 NA NA
Chuang et al. [16] 2013 1 M 19 10 12 42.3/30.2 12.1 69.9 8.6/8.8 +0.2 115/90 -25 DyslipidemiaOSAQoL DKA, mild hypoglycemic episodes
Raab et al. [17] 2013 1 F 38 19 12 37.3/25.3 12.0 97.6 7.4/7.2 −0.2 88.6/48 -39.4 NA NA
Tang et al. [18] 2014 1 F 38 28 31 54.5/40.5 14.0 47.5 9.9/10.1-11.4 +0.2-1.5 46/25 -21 NA NA
1 F 31 13 9 49.1/37.6 11.5 47.7 6.7/7.8-8.3 +1.1-1.6 60/26 -34 NA NA
Al Sabah et al. [19] 2017 10 F/5(50%) 34.1±12.6 NA 48 (6-96) 41.9±5.4/31.4±8.4 10.5* 74.4±25.3a 8.6±1.2/8.3±1.4 −0.3 76±68/ 18±18 -58* No improvement of cholesterol level 18.2% hypoglycemia
Kc et al. [20] 2018 1 F 46 36 3 39/33.1 5.9 42.1 9.8/8 −1.8 31/27.6 -3.4 NA None

*P<0.05.

a% Excess weight loss, NA = not applicable, OSA = obstructive sleep apnea, QoL = quality of life, DKA = diabetic ketoacidosis.

J Metab Bariatr Surg 2020;9:52-60 https://doi.org/10.17476/jmbs.2020.9.2.52
© 2020 J Metab Bariatr Surg